“…At the same time, cationic PSs can also target the suborganelles of cancer cells, which can promote a series of inammatory and immune responses by the ROS produced during PDT, destroy the tumor microvasculature, and ultimately induce tumor cell death. [26][27][28] However, cationic PSs can still be induced to aggregate by the physiological environment, biological polyanions (e.g., adenosine triphosphates (ATP) and pyrophosphate (PPi)), and high ionic strength, resulting in serious uorescence quenching which greatly limits the potential in vivo applications. 7,29,30 Therefore, it is very promising to develop cationic molecular PSs with excellent anti-ACQ properties in a physiological environment.…”